Restart Life Sciences Corp. (CSE:HEAL)

Canada flag Canada · Delayed Price · Currency is CAD
0.0700
-0.0200 (-22.22%)
Sep 16, 2025, 2:59 PM EDT
-22.22%
Market Cap2.52M
Revenue (ttm)n/a
Net Income (ttm)-562.53K
Shares Out36.05M
EPS (ttm)-0.03
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume8,400
Average Volume39,312
Open0.0700
Previous Close0.0900
Day's Range0.0700 - 0.0700
52-Week Range0.0250 - 0.1750
Beta-0.43
RSI42.12
Earnings DateAug 27, 2025

About Restart Life Sciences

Restart Life Sciences Corp., through its subsidiaries, operates as a biotechnology company worldwide. It engages in developing natural remedies specifically tailored for individuals on the autism spectrum; health-related foods that promote both mind and body wellness for healthy living, as well as psilocybin clinical trial for fragile X syndrome. The company was formerly known as Nova Mentis Life Science Corp. and changed its name to Restart Life Sciences Corp. in November 2024. Restart Life Sciences Corp. was incorporated in 2004 and is based ... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2004
Country Canada
Stock Exchange Canadian Securities Exchange
Ticker Symbol HEAL
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.